RNAC R&D Expenses
Cartesian Therapeutics Inc · R&D Expenses
RNAC R&D Expenses
Latest reported$68.39Mperiod ending
RNAC TTM R&D Expenses ($22.98M → $68.39M)
TTM R&D Expenses
High-resolution chart · PNG
RNAC r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 68,385,000 | |
| 62,823,000 | |
| 58,034,000 | |
| 54,651,000 | |
| 52,249,000 | |
| 50,041,000 | |
| 45,105,000 | |
| 56,230,000 | |
| 57,832,000 | |
| 62,953,000 | |
| 71,839,000 | |
| 68,375,000 | |
| 71,912,000 | |
| 73,312,000 | |
| 72,377,000 | |
| 73,728,000 | |
| 78,140,000 | |
| 73,421,000 | |
| 68,736,000 | |
| 63,509,000 | |
| 56,518,000 | |
| 52,785,000 | |
| 54,505,000 | |
| 54,566,000 | |
| 48,710,000 | |
| 50,114,000 | |
| 42,743,000 | |
| 37,847,000 | |
| 41,628,000 | |
| 43,901,000 | |
| 47,687,000 | |
| 51,054,000 | |
| 48,673,000 | |
| 45,260,000 | |
| 45,165,000 | |
| 42,575,000 | |
| 39,092,000 | |
| 34,098,000 | |
| 29,702,000 | |
| 25,880,000 | |
| 25,342,000 | |
| 24,656,000 | |
| 22,980,000 |